Skip to content

Contemporary Drug Problems

ISSN 0091-4509

8 papers in the library · 193 citations · publishing 2002-2026

Papers

Tracing the “Event” of Drug Use: “Context” and the Coproduction of a Night Out on MDMA

Contemporary Drug Problems September 1, 2014 Ella Dilkes‐frayne 65 citations

Current research on youth illicit drug use often examines 'context' as a mediating factor, but this approach misses the temporality, dynamism, and multiplicity of actual drug-taking. Drawing on Actor Network Theory, the author conceptualizes a drug-use event as a process of successive mediations, where shifting relations bring about transformations and actions including drug use. The article discusses methodological aspects of tracing such events and provides an account of a young man taking MDMA at a music festival in Melbourne, Australia. This approach offers a new way to rethink contextual influences on drug use and could assist harm reduction efforts.

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

Contemporary Drug Problems September 1, 2019 Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers 50 citations

Motives for using novel psychoactive substances (NPS) are largely similar to those for classical psychoactive substances (CPS), except for synthetic cannabinoids, whose main endorsed motive is getting intoxicated without regard to specific qualities. Across 12 substances, the most common motives are feeling euphoric (58.0%), enhancing an activity (52.3%), and broadening consciousness (48.1%). Coping-related reasons are more frequent among female participants, while males indicate a broader range of motives. These patterns can inform tailored educational campaigns and prevention strategies.

“Dancestasy”: Dance and MDMA Use in Dutch Youth Culture

Contemporary Drug Problems March 1, 2002 Tom Ter Bogt, Rutger C. M. E. Engels, Belinda Hibbel et al. 46 citations

House music was the dominant youth subculture in the Netherlands during the 1980s and 1990s, centered on all-night parties and MDMA (Ecstasy) use. The article reviews the history of the Dutch house scene and examines the psychological effects of dancing while on MDMA, termed "dancestasy." Although MDMA can be physically and cognitively harmful, the dancestasy experience may positively contribute to personal and social identity development in adolescence. Ethnographic studies suggest temporary negative effects on school or work functioning. After several years in the scene, leisure time becomes less important, and young adults resume social responsibilities.

Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services?

Contemporary Drug Problems August 29, 2022 Liam B. Engel, S. Thal, S. Bright 29 citations

People who use psychedelics prefer trip sitters—caregivers who monitor them during a session—to have personal experience with psychedelics or other non-ordinary states of consciousness, knowledge of health and medical fields, and familiarity with psychedelic literature. Forum discussions on The Shroomery and DMT Nexus also reveal a demand for remote trip sitting, where consumers communicate plans online to a sitter who is not physically present, balancing privacy with care. These preferences likely stem from stigma and the value of empathy; trip sitters with lived experience can relate to the effects and help consumers avoid judgment. The findings suggest that harm reduction services should be delivered by peers and should explore remote care options.

Fear and Loathing in the United Nations: The Establishment of International Control of Psychedelics Through the 1971 Convention on Psychotropic Substances

Contemporary Drug Problems March 7, 2026 Måns Bergkvist, Damon Barrett, Johan Edman et al. 1 citation

Psychedelics were included under the 1971 Convention on Psychotropic Substances—a key international drug control treaty—due to sensationalized media coverage and Cold War politics, not strong scientific evidence of public health dangers. Concerns about dependency and youth counterculture were amplified, while tobacco, alcohol, sedatives, and stimulants faced less restriction due to cultural and economic advocacy. The United States helped preserve allowances for psychedelic research and plant use, countering stricter proposals from France and the USSR. The article shows how ideological, cultural, political, and institutional factors, rather than evidence alone, shaped international drug policy.

Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use

Contemporary Drug Problems August 28, 2025 Jason K. Day, Michael Th. Grooff 1 citation

The 1971 UN Convention on Psychotropic Substances prohibits recreational use of psychedelics like LSD, psilocybin, DMT, and mescaline, based on claims that they pose a serious public health threat due to high addiction and abuse liability and have only limited medical and scientific value. This article argues that these premises are false: psychedelics are not highly addictive or abusive, and their uses extend beyond medicine and science, making prohibition unjustified. Decriminalization and legal regulation also rest on flawed premises. The authors propose communalization, where all adults may freely use psychedelics recreationally, supported by community-based harm reduction and benefit enhancement services.

The Trouble With Psychedelic Cacti: Conflicting Meanings of San Pedro and Peyote

Contemporary Drug Problems February 10, 2025 Liam B. Engel, Mitchell Low 1 citation

Conflicts around the mescaline cacti San Pedro and Peyote arise from tensions between Indigenous cultural practices, psychopharmacotherapy research, psychedelic markets, and ecology. Through autoethnography, the authors reflect on their lived experiences with growing, researching, and working with these plants. They find that powers of medicine and prohibition dominate among diverse stakeholders, but these powers are also met with resistance.

The Entrepreneurship of Psychedelic Negativity: Psymposia, Trauma, Iatrogenic Harm, and Prohibition 2.0

Contemporary Drug Problems July 10, 2026 Oliver Davis, Sophie Casey

A skeptical analysis of Psymposia, a U.S.-based psychedelics watchdog group, argues that its campaign against MDMA-assisted therapy for PTSD—including its "Power Trip" podcast, FDA hearing interventions, and allegations of a "Psychedelic Syndicate"—constituted an effective entrepreneurship of psychedelic negativity. The group employed sensationalism and a narrow definition of iatrogenic harm to present its activism as harm reduction, while objectively conspiring to produce Prohibition 2.0 through distributed anxiogenesis. Psymposia received over $400,000 in funding, mostly from undisclosed sources, some likely used for communications consultancy and media access. The authors reject the group's position as incoherent and damaging to substantive Left politics, arguing its exaggerated influence reflects unusual conditions of knowledge production in psychedelic spaces and the online attentional economy.